Bone Marrow Transplantation - Table of Contents alert Volume 53 Issue n9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 53, Issue 9 In this issue Editorial Article Technical Report Correspondence Also new AOP   Editorial The good, the bad and the ugly Shaun McCann Bone Marrow Transplantation 2018 53 :1087 - 1088; August 01, 2018; 10.1038/s41409-018-0237-y   Abstract | Full Text Article Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation Zhiheng Cheng, Lei Zhou, Kai Hu, Yifeng Dai, Yifan Pang et al. Bone Marrow Transplantation 2018 53 :1089 - 1095; March 07, 2018; 10.1038/s41409-018-0146-0   Abstract | Full Text Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years Mathias Debals-Gonthier, Carole Siani, Catherine Faucher, Rajae Touzani, Claude Lemarié-Basset et al. Bone Marrow Transplantation 2018 53 :1096 - 1104; March 09, 2018; 10.1038/s41409-018-0133-5   Abstract | Full Text Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma Yoshitaka Inoue, Shigeo Fuji, Ryuji Tanosaki, Yoshihiro Inamoto, Takashi Tanaka et al. Bone Marrow Transplantation 2018 53 :1105 - 1115; March 09, 2018; 10.1038/s41409-018-0139-z   Abstract | Full Text Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma Chong Chyn Chua, Hui Yin Lim, Khai Li Chai, Jeremy Ong, Shirlene Sim et al. Bone Marrow Transplantation 2018 53 :1116 - 1123; March 09, 2018; 10.1038/s41409-018-0152-2   Abstract | Full Text Bortezomib is safe in and stabilizes pulmonary function in patients with allo-HSCT-associated pulmonary CGVHD Manu Jain, GRS Budinger, Borko Jovanovic, Jane Dematte, Sara Duffey et al. Bone Marrow Transplantation 2018 53 :1124 - 1130; March 09, 2018; 10.1038/s41409-018-0134-4   Abstract | Full Text Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities Jan Styczynski, Gloria Tridello, J. Peter Donnelly, Simona Iacobelli, Jennifer Hoek et al. Bone Marrow Transplantation 2018 53 :1131 - 1138; March 13, 2018; 10.1038/s41409-018-0141-5   Abstract | Full Text Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report Jakob R Passweg, Helen Baldomero, Peter Bader, Grzegorz W. Basak, Chiara Bonini et al. Bone Marrow Transplantation 2018 53 :1139 - 1148; March 14, 2018; 10.1038/s41409-018-0153-1   Abstract | Full Text Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease Lambros Kordelas, Fabiola da Silva Nardi, Bettina Wagner, Markus Ditschkowski, Tobias Liebregts et al. Bone Marrow Transplantation 2018 53 :1149 - 1156; March 14, 2018; 10.1038/s41409-018-0145-1   Abstract | Full Text Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases Fausta Beneventi, Elena Locatelli, Margherita Simonetta, Chiara Cavagnoli, Raffaella Pampuri et al. Bone Marrow Transplantation 2018 53 :1157 - 1164; March 15, 2018; 10.1038/s41409-018-0149-x   Abstract | Full Text High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group Adam Gassas, Ponni Sivaprakasam, Michelle Cummins, Patricia Breslin, Katharine Patrick et al. Bone Marrow Transplantation 2018 53 :1165 - 1169; March 15, 2018; 10.1038/s41409-018-0157-x   Abstract | Full Text Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community Ameera Gaafar, Atia Sheereen, Fahad Almohareb, Abdelmoneim Eldali, Naeem Chaudhri et al. Bone Marrow Transplantation 2018 53 :1170 - 1179; March 16, 2018; 10.1038/s41409-018-0123-7   Abstract | Full Text Technical Report Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis Anne-Pauline Bellanger, Ana Berceanu, Steffi Rocchi, Benoit Valot, Jean Fontan et al. Bone Marrow Transplantation 2018 53 :1180 - 1183; April 30, 2018; 10.1038/s41409-018-0194-5   Abstract | Full Text Correspondence Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience Richard J. Lin, Armin Shahrokni, Parastoo B. Dahi, Ann A. Jakubowski, Sean M. Devlin et al. Bone Marrow Transplantation 2018 53 :1184 - 1187; March 09, 2018; 10.1038/s41409-018-0151-3   Abstract | Full Text Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation Volker Schmidt, Dietger Niederwieser, Thomas Schenk, Gerhard Behre, Anne Klink et al. Bone Marrow Transplantation 2018 53 :1188 - 1192; March 15, 2018; 10.1038/s41409-018-0135-3   Abstract | Full Text Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) Elio Castagnola, Francesca Bagnasco, Stefania Menoni, Monica Muraca, Arcangelo Prete et al. Bone Marrow Transplantation 2018 53 :1193 - 1197; March 21, 2018; 10.1038/s41409-018-0160-2   Abstract | Full Text Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma Rahul Naithani, Nitin Dayal, Sangeeta Pathak & Reeta Rai Bone Marrow Transplantation 2018 53 :1198 - 1200; March 29, 2018; 10.1038/s41409-018-0174-9   Abstract | Full Text Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP Raffaella Greco, Fabio Ciceri, Maddalena Noviello, Attilio Bondanza, Luca Vago et al. Bone Marrow Transplantation 2018 53 :1201 - 1205; April 17, 2018; 10.1038/s41409-018-0167-8   Abstract | Full Text Alveolar levels of immuno-inflammatory mediators in diffuse alveolar hemorrhage after allogeneic transplant Lisa K. Vande Vusse, Mark M. Wurfel, David M. Madtes, H. Gary Schoch, Susanna Harju-Baker et al. Bone Marrow Transplantation 2018 53 :1206 - 1209; April 18, 2018; 10.1038/s41409-018-0168-7   Abstract | Full Text Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective Talha Badar, Parameswaran Hari, Saurabh Chhabra, Binod Dhakal, William R. Drobyski et al. Bone Marrow Transplantation 2018 53 :1210 - 1213; April 20, 2018; 10.1038/s41409-018-0178-5   Abstract | Full Text Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet’s disease and secondary myelodysplastic syndrome Maiko Noguchi, Hiroshi Moritake, Sachiyo Kamimura, Motoshi Sonoda, Masataka Ishimura et al. Bone Marrow Transplantation 2018 53 :1214 - 1217; April 27, 2018; 10.1038/s41409-018-0180-y   Abstract | Full Text Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation Kyle R. Brownback, Lucas R. Pitts & Sunil Abhyankar Bone Marrow Transplantation 2018 53 :1218 - 1220; April 26, 2018; 10.1038/s41409-018-0182-9   Abstract | Full Text Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen Karen Sweiss, Annie Oh, Gregory Calip, Damiano Rondelli & Pritesh Patel Bone Marrow Transplantation 2018 53 :1221 - 1224; April 27, 2018; 10.1038/s41409-018-0195-4   Abstract | Full Text Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers Fatima Aerts-Kaya, Gül Koca, Parisa Sharafi, Funda Çakmak Sayla, Duygu Uçkan-Çetinkaya et al. Bone Marrow Transplantation 2018 53 :1225 - 1227; April 27, 2018; 10.1038/s41409-018-0192-7   Abstract | Full Text Trends and outcomes-first 100 bone marrow transplants at a Tertiary Care Center in Islamabad, Pakistan Fahad Mushtaq, Umer Farooq, Kamran Rashid, Ayesha Junaid, Tahir Aziz et al. Bone Marrow Transplantation 2018 53 :1228 - 1230; May 08, 2018; 10.1038/s41409-018-0210-9   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.